| Sireesha Dasari, MD | |
|
2610 Camden Ave, Parkersburg, WV 26101-5652 | |
| (304) 917-3733 | |
| (304) 917-3744 |
| Full Name | Sireesha Dasari |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 2610 Camden Ave, Parkersburg, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386855484 | NPI | - | NPPES |
| 381001660 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 23651 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of West Virginia | Vienna, WV | Home health agency |
| Camden Clark Medical Center | Parkersburg, WV | Hospital |
| Marietta Memorial Hospital | Marietta, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wirt County Health Services Association, Inc | 7810806577 | 23 |
News Archive
Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.
Today, Grifols SA announced that it has reached an agreement with the Swedish company Pharmalink AB to acquire various forms of intellectual property associated with the treatment of post-polio syndrome. The acquisition is expected to be finalized in the next few weeks and will include documentation, know-how, and Swedish regulatory approvals under the trade name Xepol.
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Toxic algae blooms in lakes and reservoirs are highly destructive, resulting in fish kills and toxicity risks to wildlife, livestock - and even humans. But their development is difficult to predict.
A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest in elderly patients, raising concerns whether current treatment strategies are optimal for this patient group.
› Verified 8 days ago
| Entity Name | Seshagiri Kalapala |
|---|---|
| Entity Type | Practitioner - Physical Medicine And Rehabilitation |
| Entity Identifiers | NPI Number: 1730267030 PECOS PAC ID: 5597803395 Enrollment ID: I20091116000627 |
News Archive
Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.
Today, Grifols SA announced that it has reached an agreement with the Swedish company Pharmalink AB to acquire various forms of intellectual property associated with the treatment of post-polio syndrome. The acquisition is expected to be finalized in the next few weeks and will include documentation, know-how, and Swedish regulatory approvals under the trade name Xepol.
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Toxic algae blooms in lakes and reservoirs are highly destructive, resulting in fish kills and toxicity risks to wildlife, livestock - and even humans. But their development is difficult to predict.
A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest in elderly patients, raising concerns whether current treatment strategies are optimal for this patient group.
› Verified 8 days ago
| Entity Name | Wirt County Health Services Association, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760733984 PECOS PAC ID: 7810806577 Enrollment ID: O20140317001851 |
News Archive
Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.
Today, Grifols SA announced that it has reached an agreement with the Swedish company Pharmalink AB to acquire various forms of intellectual property associated with the treatment of post-polio syndrome. The acquisition is expected to be finalized in the next few weeks and will include documentation, know-how, and Swedish regulatory approvals under the trade name Xepol.
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Toxic algae blooms in lakes and reservoirs are highly destructive, resulting in fish kills and toxicity risks to wildlife, livestock - and even humans. But their development is difficult to predict.
A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest in elderly patients, raising concerns whether current treatment strategies are optimal for this patient group.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sireesha Dasari, MD Po Box 609, Elizabeth, WV 26143-0609 Ph: (304) 275-3301 | Sireesha Dasari, MD 2610 Camden Ave, Parkersburg, WV 26101-5652 Ph: (304) 917-3733 |
News Archive
Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.
Today, Grifols SA announced that it has reached an agreement with the Swedish company Pharmalink AB to acquire various forms of intellectual property associated with the treatment of post-polio syndrome. The acquisition is expected to be finalized in the next few weeks and will include documentation, know-how, and Swedish regulatory approvals under the trade name Xepol.
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Toxic algae blooms in lakes and reservoirs are highly destructive, resulting in fish kills and toxicity risks to wildlife, livestock - and even humans. But their development is difficult to predict.
A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest in elderly patients, raising concerns whether current treatment strategies are optimal for this patient group.
› Verified 8 days ago
Tara Lynn Staats, NP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Rosemar Cir, Parkersburg, WV 26104 Phone: 304-865-5130 Fax: 304-485-1519 | |
Brian Powderly, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2675 36th St, Parkersburg, WV 26104 Phone: 304-422-8112 Fax: 304-422-3924 | |
Ellen Renee Brown, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 184 Holiday Hills Dr, Parkersburg, WV 26104 Phone: 304-420-2400 Fax: 304-420-9014 | |
Stacie D Gump, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2838 Pike Street, Wvu Medicine Patriot Pointe Camden Clark Physici Corpor, Parkersburg, WV 26101 Phone: 304-865-5070 Fax: 304-489-4250 | |
Dr. Terry William Capel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 418 Grand Park Dr Ste 311, Parkersburg, WV 26105 Phone: 304-865-5120 | |
Stephan D Hanna, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1907 Ann St, Parkersburg, WV 26101 Phone: 304-424-4205 Fax: 304-424-4485 | |
Dr. John Edward Beane, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Rosemar Cir, Parkersburg, WV 26104 Phone: 304-485-6130 Fax: 304-485-1519 |